Rapamycin Alleviates Protein Aggregates, Reduces Neuroinflammation, and Rescues Demyelination in Globoid Cell Leukodystrophy
Cells · 2023
DOI: 10.3390/cells12070993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Dar-Shong Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, MacKay Memorial Hospital, Taipei 10449, Taiwan. Hauptthemen laut MEDLINE: Leukodystrophy, Globoid Cell, Demyelinating Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, MacKay Memorial Hospital.
Abstract (Originalsprache)
We have shown in vivo and in vitro previously that psychosine causes dysfunction of autophagy and the ubiquitin-proteasome system underlying the pathogenesis of globoid cell leukodystrophy (GLD), a devastating lysosomal storage disease complicated by global demyelination. Here, we investigated the therapeutic efficacy of the mTOR inhibitor rapamycin in twitcher mice, a murine model of infantile GLD, in biochemical, histochemical, and clinical aspects. Administration of rapamycin to twitcher mice inhibited mTOR signaling in the brains, and significantly reduced the accumulation of insoluble ubiquitinated protein and the formation of ubiquitin aggregates. The astrocytes and microglia reactivity were attenuated in that reactive astrocytes, ameboid microglia, and globoid cells were reduced in the brains of rapamycin-treated twitcher mice. Furthermore, rapamycin improved the cortical myelination, neurite density, and rescued the network complexity in the cortex of twitcher mice. The therapeutic action of rapamycin on the pathology of the twitcher mice’s brains prolonged the longevity of treated twitcher mice. Overall, these findings validate the therapeutic efficacy of rapamycin and highlight enhancing degradation of aggregates as a therapeutic strategy to modulate neuroinflammation, demyelination, and disease progression of GLD and other leukodystrophies associated with intracellular aggregates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, MacKay Memorial Hospital, Taipei 10449, Taiwan.
- Department of Medicine, MacKay Medical College, New Taipei 25245, Taiwan.
- Department of Medical Research, MacKay Memorial Hospital, Taipei 10449, Taiwan.
- Department of Laboratory Medicine, MacKay Memorial Hospital, Taipei 10449, Taiwan.
- Department of Neurology, MacKay Children's Hospital, Taipei 10449, Taiwan.
Förderung
- National Science and Technology Council
- MacKay Memorial Hospital
Zitieren
APA
Lin, D. S., Huang, Y. W., Lee, T. H., Chang, L., Huang, Z. D., Wu, T. Y., Wang, T. J., & Ho, C. S. (2023). Rapamycin Alleviates Protein Aggregates, Reduces Neuroinflammation, and Rescues Demyelination in Globoid Cell Leukodystrophy. Cells. https://doi.org/10.3390/cells12070993
Vancouver
Lin DS, Huang YW, Lee TH, Chang L, Huang ZD, Wu TY, et al. Rapamycin Alleviates Protein Aggregates, Reduces Neuroinflammation, and Rescues Demyelination in Globoid Cell Leukodystrophy. Cells. 2023. doi:10.3390/cells12070993
BibTeX
@article{Lin2023,
author = {Lin, Dar-Shong and Huang, Yu-Wen and Lee, Tsung-Han and Chang, Lung and Huang, Zon-Darr and Wu, Tsu-Yen and Wang, Tuan-Jen and Ho, Che-Sheng},
title = {Rapamycin Alleviates Protein Aggregates, Reduces Neuroinflammation, and Rescues Demyelination in Globoid Cell Leukodystrophy},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12070993}
}
EUVIMED